Evolution’s Blueprint: How AI and CT Scans are Unlocking the ₹1.5 Lakh Crore Secret of India’s Ancient Serpents
Evolution’s Blueprint: How AI and CT Scans are Unlocking the ₹1.5 Lakh Crore Secret of India’s Ancient Serpents

Evolution’s Blueprint: How AI and CT Scans are Unlocking the ₹1.5 Lakh Crore Secret of India’s Ancient Serpents

Indian researchers are leveraging advanced CT scanning and AI to decode the 100-million-year evolution of snakes from their limbed ancestors. This digital resurrection is transforming our understanding of biodiversity and the high-stakes pharmaceutical potential of ancient venom lineages.

0 Comments
Nvidia’s $13 “Sidewalk Warrior”: Serve Robotics and Anduril Join Forces to Redefine India’s Autonomous Security
Nvidia’s $13 “Sidewalk Warrior”: Serve Robotics and Anduril Join Forces to Redefine India’s Autonomous Security

Nvidia’s $13 “Sidewalk Warrior”: Serve Robotics and Anduril Join Forces to Redefine India’s Autonomous Security

A $13 Nvidia-backed startup is teaming up with defense giant Anduril to turn sidewalk robots into security assets. For India's growing autonomous tech sector, this partnership represents a blueprint for merging commercial logistics with national defense.

0 Comments
Molecular Code-Breakers: How Generative AI is Rewriting India’s ₹1.5 Lakh Crore Antibiotic Playbook
Molecular Code-Breakers: How Generative AI is Rewriting India’s ₹1.5 Lakh Crore Antibiotic Playbook

Molecular Code-Breakers: How Generative AI is Rewriting India’s ₹1.5 Lakh Crore Antibiotic Playbook

India is pivoting its ₹1.5 lakh crore pharmaceutical engine toward AI-driven drug discovery to defeat global superbugs. By merging Nvidia-powered computing with sovereign data, the nation is moving from generic manufacturing to high-value IP creation.

0 Comments
"Zero-G Pharmacy": India's ₹1.5 Lakh Crore Drug Sector Eyes Orbital Manufacturing as Space Labs Go Commercial
"Zero-G Pharmacy": India's ₹1.5 Lakh Crore Drug Sector Eyes Orbital Manufacturing as Space Labs Go Commercial

“Zero-G Pharmacy”: India’s ₹1.5 Lakh Crore Drug Sector Eyes Orbital Manufacturing as Space Labs Go Commercial

India's pharmaceutical giants are looking to the stars as space-based drug manufacturing goes commercial, promising a new era of molecular perfection. With ISRO's low-cost launches, the nation is poised to lead the 'Orbital Apothecary' revolution.

0 Comments